51 related articles for article (PubMed ID: 2674867)
1. [Modification of aerobic digestive flora in patients in intensive care during and after treatment with cefmenoxime].
Poisson DM; Martin P; Bidault C; Gueveler C
Pathol Biol (Paris); 1989 May; 37(5):350-2. PubMed ID: 2674867
[TBL] [Abstract][Full Text] [Related]
2. [Effect of aztreonam on the fecal aerobic flora in children].
Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
[TBL] [Abstract][Full Text] [Related]
3. [Effect of ceftriaxone on aerobic fecal flora in children].
Borderon JC; Rastegar A; Saliba E; Laugier J; Despert F
Pathol Biol (Paris); 1990 Sep; 38(7):716-8. PubMed ID: 2235086
[TBL] [Abstract][Full Text] [Related]
4. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.
Guggenbichler JP; Allerberger FJ; Dierich M
Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044
[TBL] [Abstract][Full Text] [Related]
5. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu.
Walson JL; Marshall B; Pokhrel BM; Kafle KK; Levy SB
J Infect Dis; 2001 Nov; 184(9):1163-9. PubMed ID: 11598839
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
[TBL] [Abstract][Full Text] [Related]
8. Resistance of bacteria from human faecal flora to antimicrobial agents.
Ismaeel NA
J Trop Med Hyg; 1993 Feb; 96(1):51-5. PubMed ID: 8429575
[TBL] [Abstract][Full Text] [Related]
9. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Husson MO; Bryskier A; Izard D; Leclerc H
Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
[TBL] [Abstract][Full Text] [Related]
10. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
11. Effects of imipenem, cefotaxime and cotrimoxazole on aerobic microbial colonization of the digestive tract.
Van der Leur JJ; Thunnissen PL; Clasener HA; Muller NF; Dofferhoff AS
Scand J Infect Dis; 1993; 25(4):473-8. PubMed ID: 8248747
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic sensitivity of gram-negative opportunistic bacteria isolated from the feces of newborn infants with intestinal infections].
Litiaeva LA; Zakopaeva ES
Antibiot Khimioter; 1989 Jan; 34(1):66-8. PubMed ID: 2730219
[TBL] [Abstract][Full Text] [Related]
13. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis.
Borzio M; Salerno F; Saudelli M; Galvagno D; Piantoni L; Fragiacomo L
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):262-6. PubMed ID: 9646219
[TBL] [Abstract][Full Text] [Related]
15. Cefmenoxime therapy for gynecologic and obstetric infections.
Rao B; Savage EW; Chuah SK; Bansal MB; Dhawan VK; Thadepalli H
Obstet Gynecol; 1985 Sep; 66(3):377-83. PubMed ID: 3860790
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance pattern among aerobic gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre.
Kumari HB; Nagarathna S; Chandramuki A
Indian J Chest Dis Allied Sci; 2007; 49(1):19-22. PubMed ID: 17256562
[TBL] [Abstract][Full Text] [Related]
17. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
Nakatomi M; Neu HC
Chemioterapia; 1986 Dec; 5(6):379-84. PubMed ID: 3802298
[TBL] [Abstract][Full Text] [Related]
18. Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man.
Hartley CL; Clements HM; Linton KB
J Med Microbiol; 1978 May; 11(2):125-35. PubMed ID: 660638
[TBL] [Abstract][Full Text] [Related]
19. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.
van Ogtrop ML; Guiot HF; Mattie H; van Strijen E; Sekh BR; van Furth R
Antimicrob Agents Chemother; 1991 May; 35(5):983-5. PubMed ID: 1854181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
